OBJECTIVE -To assess the occurrence and development of new peripheral arterial occlusive disease (PAOD), its risk factors, and the outcome in patients with type 2 diabetes.
RESEARCH DESIGN AND METHODS-A total of 130 type 2 diabetic patients (mean age 58 years) were examined at baseline and after a mean follow-up of 11 years (range 7-14). The ankle-brachial index (ABI) and toe-brachial index were used to detect PAOD. Blood and urine samples were taken at baseline, and a history of cardiovascular events was recorded during follow-up.RESULTS -PAOD was diagnosed in 21 (16%) patients at baseline. During follow-up, 21 of 89 (24%) patients developed new PAOD. There were 29 patients who died, 21 (72%) of them from cardiovascular disease. Patients with PAOD suffered an excess mortality compared with patients without PAOD (58 vs. 16%; P Ͻ 0.001). Logistic regression analysis showed that PAOD at baseline was associated with age, duration of diabetes, smoking, and urinary albumin excretion rate. Patients who developed new PAOD during follow-up had higher serum LDL cholesterol concentrations and lower HDL cholesterol concentrations and were older than the patients who remained free of PAOD.CONCLUSIONS -Objectively measured PAOD is frequent in type 2 diabetic patients. It presents the early clinical signs of atherosclerosis and is strongly associated with cardiovascular death. The risk factor pattern for PAOD was different at baseline and after a mean follow-up of 11 years. We consider routine ABI measurements and modification of risk factors necessary also in patients with asymptomatic PAOD.
Diabetes Care 26:1241-1245, 2003I n patients with type 2 diabetes, peripheral arterial occlusive disease (PAOD) is a major contributor to diabetic foot problems. Identification of PAOD is essential because, in many cases, appropriate treatment saves the diabetic foot (1). Further, prevention of foot problems may be easier than treating foot problems. For this purpose, specific risk factors for the development of PAOD need to be recognized.Follow-up studies on risk factors for objectively measured PAOD in patients with type 2 diabetes are few, and the follow-up times are short (2-4 years) (2-4). Some evidence suggests that general risk factors of atherosclerosis such as systolic hypertension, smoking, dyslipidemia, and age are also risk factors for progression of PAOD (2,4). A recent study proposed that HbA 1c , LDL cholesterol, and smoking are risk factors for development of new PAOD in patients with type 1 diabetes (5), but no similar data are available for type 2 diabetes.Objectively measured PAOD predicts cardiovascular death and morbidity both in the general population and the diabetic population (2,6,7). Therefore, the following question arises: Could objectively measured PAOD be the first clinical sign of cardiovascular disease?The diagnosis of PAOD is critical. Palpation of pulses and a history of claudication detect PAOD inadequately; therefore, PAOD should be assessed by objective noninvasive measurements (8). The ankle-brachial...